Enliven Therapeutics
ELVN
ELVN
34 hedge funds and large institutions have $302M invested in Enliven Therapeutics in 2020 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0.56% less ownership
Funds ownership: 16.38% → 15.82% (-0.56%)
Holders
34
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$16.2M | |
| 2 | +$9.48M | |
| 3 | +$4.4M | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$2.27M |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$1.59M |
Top Sellers
| 1 | -$17.3M | |
| 2 | -$4.12M | |
| 3 | -$3.82M | |
| 4 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
-$2.24M |
| 5 |
DM
Deerfield Management
New York
|
-$2.1M |